Literature DB >> 21172665

TDRD3 is an effector molecule for arginine-methylated histone marks.

Yanzhong Yang1, Yue Lu, Alexsandra Espejo, Jiacai Wu, Wei Xu, Shoudan Liang, Mark T Bedford.   

Abstract

Specific sites of histone tail methylation are associated with transcriptional activity at gene loci. These methyl marks are interpreted by effector molecules, which harbor protein domains that bind the methylated motifs and facilitate either active or inactive states of transcription. CARM1 and PRMT1 are transcriptional coactivators that deposit H3R17me2a and H4R3me2a marks, respectively. We used a protein domain microarray approach to identify the Tudor domain-containing protein TDRD3 as a "reader" of these marks. Importantly, TDRD3 itself is a transcriptional coactivator. This coactivator activity requires an intact Tudor domain. TDRD3 is recruited to an estrogen-responsive element in a CARM1-dependent manner. Furthermore, ChIP-seq analysis of TDRD3 reveals that it is predominantly localized to transcriptional start sites. Thus, TDRD3 is an effector molecule that promotes transcription by binding methylarginine marks on histone tails.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172665      PMCID: PMC3090733          DOI: 10.1016/j.molcel.2010.11.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  34 in total

1.  Tudor, MBT and chromo domains gauge the degree of lysine methylation.

Authors:  Jeesun Kim; Jeremy Daniel; Alexsandra Espejo; Aimee Lake; Murli Krishna; Li Xia; Yi Zhang; Mark T Bedford
Journal:  EMBO Rep       Date:  2006-01-13       Impact factor: 8.807

2.  The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing.

Authors:  Donghang Cheng; Jocelyn Côté; Salam Shaaban; Mark T Bedford
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

Review 3.  Reprogramming mRNA translation during stress.

Authors:  Satoshi Yamasaki; Paul Anderson
Journal:  Curr Opin Cell Biol       Date:  2008-03-20       Impact factor: 8.382

4.  Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.

Authors:  Ernesto Guccione; Christian Bassi; Fabio Casadio; Francesca Martinato; Matteo Cesaroni; Henning Schuchlautz; Bernhard Lüscher; Bruno Amati
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

5.  p53 is regulated by the lysine demethylase LSD1.

Authors:  Jing Huang; Roopsha Sengupta; Alexsandra B Espejo; Min Gyu Lee; Jean A Dorsey; Mario Richter; Susanne Opravil; Ramin Shiekhattar; Mark T Bedford; Thomas Jenuwein; Shelley L Berger
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

6.  Arginine methylation of the histone H3 tail impedes effector binding.

Authors:  Aimee N Iberg; Alexsandra Espejo; Donghang Cheng; Daehoon Kim; Jonathan Michaud-Levesque; Stephane Richard; Mark T Bedford
Journal:  J Biol Chem       Date:  2007-12-11       Impact factor: 5.157

7.  PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation.

Authors:  Dawin Hyllus; Claudia Stein; Kristin Schnabel; Emile Schiltz; Axel Imhof; Yali Dou; James Hsieh; Uta-Maria Bauer
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

8.  CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.

Authors:  Seth Frietze; Mathieu Lupien; Pamela A Silver; Myles Brown
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

9.  Protein lysine methyltransferase G9a acts on non-histone targets.

Authors:  Philipp Rathert; Arunkumar Dhayalan; Marie Murakami; Xing Zhang; Raluca Tamas; Renata Jurkowska; Yasuhiko Komatsu; Yoichi Shinkai; Xiaodong Cheng; Albert Jeltsch
Journal:  Nat Chem Biol       Date:  2008-04-27       Impact factor: 15.040

10.  The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation.

Authors:  Markus A Kleinschmidt; Gundula Streubel; Birgit Samans; Michael Krause; Uta-Maria Bauer
Journal:  Nucleic Acids Res       Date:  2008-04-15       Impact factor: 16.971

View more
  103 in total

1.  Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription.

Authors:  Jiacai Wu; Wei Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 2.  Histone arginine methylation.

Authors:  Alessandra Di Lorenzo; Mark T Bedford
Journal:  FEBS Lett       Date:  2010-11-11       Impact factor: 4.124

3.  In situ histone landscape of nephrogenesis.

Authors:  Nathan McLaughlin; Fenglin Wang; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

Review 4.  Topoisomerases and the regulation of neural function.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2016-09-15       Impact factor: 34.870

Review 5.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

Review 6.  Histones: at the crossroads of peptide and protein chemistry.

Authors:  Manuel M Müller; Tom W Muir
Journal:  Chem Rev       Date:  2014-10-20       Impact factor: 60.622

Review 7.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

Review 8.  Histone-binding domains: strategies for discovery and characterization.

Authors:  Alex W Wilkinson; Or Gozani
Journal:  Biochim Biophys Acta       Date:  2014-02-11

9.  Coactivator-associated arginine methyltransferase 1 regulates fetal hematopoiesis and thymocyte development.

Authors:  Jia Li; Ziqin Zhao; Carla Carter; Lauren I R Ehrlich; Mark T Bedford; Ellen R Richie
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

Review 10.  Emerging roles for chromatin as a signal integration and storage platform.

Authors:  Aimee I Badeaux; Yang Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.